The cost-effectiveness of long-term post-treatment peer recovery support services in the United States

被引:0
|
作者
de Martell, Sierra Castedo [1 ,2 ]
Moore, Margaret Brannon [2 ]
Wang, Hannah [2 ]
Steiker, Lori Holleran
Wilkerson, J. Michael [2 ]
Ranjit, Nalini [2 ]
Mccurdy, Sheryl A. [2 ]
Brown, H. Shelton [2 ]
机构
[1] Lighthouse Inst, Chestnut Hlth Syst, Bloomington, IL USA
[2] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX USA
基金
美国国家卫生研究院;
关键词
Peer recovery support services; cost-effectiveness analysis; cost-effectiveness calculator; recovery community organizations; recovery community centers; peer coaching; SUBSTANCE-ABUSE TREATMENT; HEALTH;
D O I
10.1080/00952990.2024.2406251
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Peer recovery support services (PRSS) have been widely adopted across a variety of settings, but little is known about their economic impact.Objectives: To conduct a cost-effectiveness analysis of long-term, PRSS delivered after specialty substance use disorder (SUD) treatment (post-treatment), and to describe the development of a free, web-based cost-effectiveness calculator based on this analysis.Methods: Using publicly available data from a variety of sources, post-treatment PRSS were compared to specialty SUD treatment from the societal (broad perspective including costs like participant time) and health systems perspectives (only costs borne by health system), and in terms of quality-adjusted life years (QALYs) added and people in recovery. Whenever possible, 2019 data were used to avoid the impacts of COVID-19. Standard willingness-to-pay thresholds and additional treatment episode cost ($17,203.74) were used. One-way and probabilistic sensitivity analyses were conducted. Two recovery community organizations (RCOs) were involved in model refinement and calculator development in 2022.Results: Post-treatment PRSS were cost-effective to all thresholds and perspectives: $5,898.60 per QALY and $10,562.08 per person in recovery from the health system perspective, and $3,421.58 per QALY and $6,126.72 per person in recovery from the societal perspective, and post-treatment PRSS remained cost-effective across a variety of conditions in the sensitivity analyses. A cost-effectiveness calculator was developed from the analysis and is available at https://go.uth.edu/cea.Conclusions: In light of finding PRSS cost-effective, the expansion of PRSS across the US should continue, and may be aided by using the cost-effectiveness calculator to estimate tailored results for a specific program.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] A Preliminary Evaluation of the Cost-Effectiveness of Long-Term Post-Treatment Peer Recovery Support Services in the United States
    de Martell, Sierra Castedo
    Moore, Margaret Brannan
    Wang, Hannah
    Brown, H. Shelton, III
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [2] LONG-TERM COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS FOR SCHIZOPHRENIA IN THE UNITED STATES
    Rajagopalan, K.
    O'Day, K.
    Meyer, K.
    Pikalov, A. A., III
    Loebel, A.
    VALUE IN HEALTH, 2012, 15 (04) : A87 - A87
  • [3] The long-term cost-effectiveness of lamivudine for the treatment of chronic hepatitis B in the United States.
    Dickens, T
    Raasch, RH
    Saal, GB
    Yeh, YC
    HEPATOLOGY, 2000, 32 (04) : 590A - 590A
  • [4] Modeling the impact of a long-term horizon and multiple treatment episodes on the cost-effectiveness of alcohol treatment in the United States
    Barbosa, C.
    Dowd, W.
    Zarkin, G.
    Karriker-Jaffe, K.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 135 - 136
  • [5] Modeling the impact of a long-term horizon and multiple treatment episodes on estimates of the cost-effectiveness of alcohol treatment in the United States
    Barbosa, Carolina
    Dowd, William N.
    Karriker-Jaffe, Katherine J.
    Zarkin, Gary
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, : 2121 - 2137
  • [6] Cost-effectiveness of long-term care services in South Korea
    Kim, EY
    Yang, BM
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2005, 40 (01) : 73 - 83
  • [7] Estimating the long-term cost-effectiveness of exenatide in the United States: An adjunctive treatment for type 2 diabetes mellitus
    Minshall, Michael E.
    Oglesby, Alan K.
    Wintle, Matthew E.
    Valentine, William J.
    Roze, Stephane
    Palmer, Andrew J.
    VALUE IN HEALTH, 2008, 11 (01) : 22 - 33
  • [8] Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
    Sroczynski, G.
    Esteban, E.
    Conrads-Frank, A.
    Schwarzer, R.
    Muehlberger, N.
    Wright, D.
    Zeuzem, S.
    Siebert, U.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 34 - 50
  • [9] Cost-effectiveness analysis in long-term treatment of risk factors
    Szucs, TD
    Gutzwiller, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 128 (49) : 1958 - 1964
  • [10] A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support
    Nunes, Abraham J.
    MacArthur, Roderick G. G.
    Kim, Daniel
    Singh, Gurmeet
    Buchholz, Holger
    Chatterley, Patricia
    Klarenbach, Scott W.
    VALUE IN HEALTH, 2016, 19 (04) : 494 - 504